PMID- 36640006
OWN - NLM
STAT- MEDLINE
DCOM- 20230117
LR  - 20230415
IS  - 2589-451X (Electronic)
IS  - 0255-2922 (Print)
IS  - 0255-2922 (Linking)
VI  - 43
IP  - 1
DP  - 2023 Feb
TI  - Long-term efficacy of point application therapy on different acupoints and 
      durations in the treatment of asthma: a randomized controlled trial.
PG  - 146-153
LID - 10.19852/j.cnki.jtcm.2023.01.013 [doi]
AB  - OBJECTIVE: To optimise point application therapy for the treatment of asthma. 
      METHODS: A total of 456 patients with asthma were randomly divided into treatment 
      groups 1, 2, and 3, with 152 patients each. The Dazhui (GV14), Feishu (BL13), 
      Xinshu (BL15), Geshu (BL17), Pishu (BL20), Shenshu (BL23), and Guanyuan (CV4) 
      acupoints were selected for treatment groups 1 and 2, with 2 and 4 h of 
      application, respectively. The Feishu (BL13), Xinshu (BL15), and Geshu (BL17) 
      acupoints were selected in group 3, with 2 h of application. All patients 
      underwent application of the "prevention of disease" plaster during the dog days 
      of summer (approximately July and August each year) between 2015 and 2019. 
      RESULTS: The analysis showed that the numbers of asthma attacks and total serum 
      immunoglobulin E (IgE) levels of the three groups after treatment were 
      significantly lower than those before treatment. In addition, the reductions in 
      treatment groups 1 and 2 were more significant than those in group 3. The total 
      treatment efficacy rates and post-treatment quality of life scores of the 
      patients in treatment groups 1 and 2 were significantly higher than those in 
      group 3. CONCLUSIONS: Point application therapy can effectively improve the 
      clinical symptoms of patients with asthma, reduce the number of attacks, improve 
      the quality of life, and decrease the total serum IgE level. The choice of 
      acupuncture points, but not the length of the application time, influenced the 
      therapeutic effect of point application therapy in asthma.
FAU - Yutong, Jin
AU  - Yutong J
AD  - Department of Acupuncture and Moxibustion, the First Affiliated Hospital of 
      Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese 
      Medicine), Hangzhou 310006, China.
FAU - Lingtao, W U
AU  - Lingtao WU
AD  - Department of Massage, Hangzhou Fuyang Hospital of Traditional Chinese Medicine, 
      Hangzhou 311400, China.
FAU - Yanglu, Guo
AU  - Yanglu G
AD  - Department of Acupuncture and Moxibustion, the First Affiliated Hospital of 
      Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese 
      Medicine), Hangzhou 310006, China.
FAU - Chong, Xia
AU  - Chong X
AD  - Department of Acupuncture and Moxibustion, Hangzhou Fuyang Hospital of TCM 
      Orthopedics and Traumatology, Hangzhou 311400, China.
FAU - Binyan, Y U
AU  - Binyan YU
AD  - Department of Acupuncture and Moxibustion, the First Affiliated Hospital of 
      Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese 
      Medicine), Hangzhou 310006, China.
FAU - Lihua, Xuan
AU  - Lihua X
AD  - Department of Acupuncture and Moxibustion, the First Affiliated Hospital of 
      Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese 
      Medicine), Hangzhou 310006, China.
LA  - eng
PT  - Journal Article
PT  - Randomized Controlled Trial
PT  - Research Support, Non-U.S. Gov't
PL  - China
TA  - J Tradit Chin Med
JT  - Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan
JID - 8211546
RN  - 37341-29-0 (Immunoglobulin E)
SB  - IM
MH  - Humans
MH  - Acupuncture Points
MH  - Quality of Life
MH  - *Asthma/drug therapy
MH  - *Acupuncture Therapy
MH  - Immunoglobulin E
PMC - PMC9924751
OTO - NOTNLM
OT  - asthma
OT  - dog days of summer
OT  - point application therapy
OT  - randomized controlled trial
EDAT- 2023/01/15 06:00
MHDA- 2023/01/18 06:00
PMCR- 2023/02/15
CRDT- 2023/01/14 05:43
PHST- 2023/01/14 05:43 [entrez]
PHST- 2023/01/15 06:00 [pubmed]
PHST- 2023/01/18 06:00 [medline]
PHST- 2023/02/15 00:00 [pmc-release]
AID - 1673348066692-1853738513 [pii]
AID - 0255-2922-43-1-146 [pii]
AID - 10.19852/j.cnki.jtcm.2023.01.013 [doi]
PST - ppublish
SO  - J Tradit Chin Med. 2023 Feb;43(1):146-153. doi: 10.19852/j.cnki.jtcm.2023.01.013.